← Leaderboards
Steven Michael Johnson
Indiana University Indianapolis
$2,399,411
Attributed
$2,489,873
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $559.1K · FY2017–21$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,489,873 · 2
By mechanism
R01$2,308,948 · 1
R03$180,925 · 1
Top collaborators
- Tanya Parish2 shared
Others in their field
Other Emerging Leaders on “In Vitro”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
- Tony Moody · Duke University$34,777,314
Research focus
In VitroChaperoninAntibiotic ResistanceBacteriaInhibitor/AntagonistAntibioticsIncidenceToxic EffectCellsLeadProteinsSmall MoleculeBaseExhibitsScaffoldNovel TherapeuticsFutureDrug DevelopmentMediatingMolecularAnti-Bacterial AgentsBiologicalBiochemicalMolecular Conformation
Grant awards (8)
Selective modulation of bacterial chaperonins by targeting novel small molecule binding sites$434,059
R01 · FY2021 · GM · contact PI
Identifying GroEL inhibitors with activity against replicating and non-replicating Mycobacterium tuberculosis$83,150
R03 · FY2021 · AI · contact PI
Selective modulation of bacterial chaperonins by targeting novel small molecule binding sites$434,059
R01 · FY2020 · GM · contact PI
Identifying GroEL inhibitors with activity against replicating and non-replicating Mycobacterium tuberculosis$97,775
R03 · FY2020 · AI · contact PI
Selective modulation of bacterial chaperonins by targeting novel small molecule binding sites$434,059
R01 · FY2019 · GM · contact PI
Selective modulation of bacterial chaperonins by targeting novel small molecule binding sites$125,000
R01 · FY2019 · GM · contact PI
Selective modulation of bacterial chaperonins by targeting novel small molecule binding sites$434,059
R01 · FY2018 · GM · contact PI
Selective modulation of bacterial chaperonins by targeting novel small molecule binding sites$447,712
R01 · FY2017 · GM · contact PI